Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose adenosine infusion preconditioning in ischemic heart disease: placebo-controlled crossover study
2006-001321-25Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of adenosine in coronary arteriosclerosis (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Quantitative changes in myocardial wall velocities. Started May 2006; status: active.
02
Drugs
adenosine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-001321-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001321-25.